youtube_live
Q2 2026 earnings • released • EPS beat +101.07% • Revenue beat +0.64%
See resultschevron_right
OMCL:NASDAQ
Omnicell Inc
$35.37
arrow_downward
-4.69%(-1.74) 1D
$35.80
arrow_upward
+1.22% (+0.43)bedtimeAfter hours
Closed: Jul 31, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OMCL...
Open
$36.55
High
$37.16
Low
$35.16
Mkt. cap
1.61B
Avg. vol.
813.18K
Volume
1.12M
P/E ratio
80.17
52-wk high
$55.00
52-wk low
$29.06
EPS
$0.44
Beta
0.96
Shares outstanding
45.48M
No. of employees
4K
Open
$36.55
High
$37.16
Low
$35.16
Mkt. cap
1.61B
Avg. vol.
813.18K
Volume
1.12M
P/E ratio
80.17
52-wk high
$55.00
52-wk low
$29.06
EPS
$0.44
Beta
0.96
Shares outstanding
45.48M
No. of employees
4K
News stories
From sources across the web
Zacks
·
2 days ago
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
Simply Wall St
·
3 days ago
Stronger Q2 Results And Higher 2026 Guidance Might Change The Case For Investing In Omnicell (OMCL)
TradingView
·
3 days ago
Omnicell (OMCL) Stock Trades Down, Here Is Why
www.marketscreener.com
·
3 days ago
Omnicell, Inc. Provides Earnings Guidance for the Third Quarter 2026 and Updates Earnings Guidance Full Year 2026
Profile
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia
About Omnicell Inc
CEORandall A. Lipps
Employees3.52K
FoundedSep 1992
HeadquartersMountain View, California, United States
SectorMedical device
Websiteomnicell.com
AI content may include mistakes. Learn more